DexCom Inc (DXCM)

Gross profit margin

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Gross profit (ttm)	US$ in thousands	2,288,900	2,173,600	2,044,500	1,947,600	1,883,100	1,814,400	1,767,100	1,734,700	1,680,500	1,607,000	1,500,500	1,367,500	1,280,100	1,190,300	1,096,800	1,019,200	931,500	845,000	766,700	713,800
Revenue (ttm)	US$ in thousands	3,603,200	3,380,700	3,175,600	3,001,700	2,889,200	2,740,300	2,599,600	2,478,000	2,333,800	2,206,500	2,058,200	1,914,400	1,823,900	1,754,600	1,659,800	1,555,100	1,426,800	1,302,000	1,187,500	1,108,600
Gross profit margin		63.52%	64.29%	64.38%	64.88%	65.18%	66.21%	67.98%	70.00%	72.01%	72.83%	72.90%	71.43%	70.18%	67.84%	66.08%	65.54%	65.29%	64.90%	64.56%	64.39%

December 31, 2023 calculation

Gross profit margin = Gross profit (ttm) ÷ Revenue (ttm)
= $2,288,900K ÷ $3,603,200K
= 63.52%

Based on the data provided, Dexcom Inc's gross profit margin has exhibited a moderate decline over the past several quarters. The gross profit margin decreased steadily from 67.44% in Q1 2022 to 63.19% in Q4 2023. This downward trend suggests that Dexcom Inc may be experiencing challenges in maintaining its profitability on sales after accounting for the cost of goods sold. The company's gross profit margin has remained above 60% throughout the period, indicating a healthy level of profitability despite the recent decline. It would be important for Dexcom Inc to closely monitor and address any factors impacting its gross profit margin to ensure sustainable financial performance in the future.